Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117241) titled 'A Multicenter, Randomized, Controlled Phase II Clinical Trial of Nanocrystalline Megestrol Acetate versus Placebo for Anorexia in Patients with Unresectable Hepatocellular Carcinoma Receiving TACE Combined with Targeted and Immunotherapy' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Primary liver cancer
cachexia
anorexia
malnutrition
Intervention:
Placebo group:Use a placebo
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-22
Target Sample Size: Placebo group:44;Megestrol Acet...